European journal of immunology · 1995
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kägi D, Seiler P, Pavlovic J, Ledermann B, Bürki K, Zinkernagel R M, Hengartner H
Аннотация
In vitro, T cell-dependent cytotoxicity is mediated by two distinct mechanisms, one being perforin-, the other Fas-dependent. The contribution of both of these mechanisms to clearance of viral infections was investigated in mice for the non-cytopathic lymphocytic choriomeningitis virus (LCMV) and the cytopathic vaccinia, vesicular stomatitis (VSV) and Semliki forest (SFV) viruses. Clearance of an acute LCMV infection was mediated by the perforin-dependent mechanism without measurable involvement of the Fas-dependent pathway. For the resolution of vaccinia virus infection and for resistance against VSV and SFV, however, neither of the two pathways was required. These data suggest that perforin-dependent cytotoxicity mediated by T cells is crucial for protection against non-cytopathic viruses, whereas infections with cytopathic viruses are controlled by nonlytic T cell-dependent soluble mediators such as cytokines (IFN-gamma against vaccinia virus) and neutralizing antibodies (against VSV and SFV).
Предметные рубрики MeSH
Alphavirus InfectionsAnimalsAntibodies, ViralCytopathogenic Effect, ViralCytotoxicity, ImmunologicImmunity, InnateImmunotherapy, AdoptiveLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMembrane GlycoproteinsMiceMice, Inbred C57BLMice, Mutant StrainsMice, TransgenicPerforinPore Forming Cytotoxic ProteinsRecombinant ProteinsSemliki forest virusVacciniaVaccinia virusfas Receptor